Loading…
Unified public record assembled from the source systems listed below. Amounts describe distinct reported activity and are not added into a single influence total.
Political giving
$0
Political receipts
$0
Lobbying income
$107,835,000
Lobbying expense
—
Federal awards
—
Relationships
663
| $1,540,000 |
| — |
| lobbied by | Alliance For Biopharmaceutical Competitiveness And Innovation | $1,480,000 | — |
| lobbied by | Tax Reform Coalition | $1,270,000 | — |
| lobbied by | Tax Reform Coalition | $1,250,000 | — |
| lobbied by | Tax Reform Coalition | $1,250,000 | — |
| lobbied by | Tax Reform Coalition | $1,060,000 | — |
| lobbied by | Alliance For Biopharmaceutical Competitiveness And Innovation | $1,040,000 | — |
| lobbied by | Tax Reform Coalition | $1,010,000 | — |
| lobbied by | Alliance For Biopharmaceutical Competitiveness And Innovation | $1,010,000 | — |
| lobbied by | Tax Reform Coalition | $970,000 | — |
| lobbied by | Alliance For Biopharmaceutical Competitiveness And Innovation | $960,000 | — |
| lobbied by | Alliance For Biopharmaceutical Competitiveness And Innovation | $800,000 | — |
| lobbied by | Inc. (formerly Beam Suntory Inc.) Suntory Global Spirits | $750,000 | — |
| lobbied by | Tax Reform Coalition | $620,000 | Apr 1, 2026 – Jul 9, 2026 |
| lobbied by | Alliance For Biopharmaceutical Competitiveness And Innovation | $590,000 | — |
| lobbied by | Alliance For Biopharmaceutical Competitiveness And Innovation | $570,000 | — |
| lobbied by | Alliance For Biopharmaceutical Competitiveness And Innovation | $550,000 | Apr 1, 2026 – Jul 9, 2026 |
| lobbied by | Alliance For Biopharmaceutical Competitiveness And Innovation | $530,000 | — |
| lobbied by | Alliance For Biopharmaceutical Competitiveness And Innovation | $530,000 | — |
| lobbied by | Alliance For Biopharmaceutical Competitiveness And Innovation | $510,000 | — |
| lobbied by | R&d Alternative Simplified Credit Coalition | $490,000 | — |
| lobbied by | Tax Reform Coalition | $470,000 | — |
| lobbied by | General Motors Company | $420,000 | — |
| lobbied by | Procter & Gamble Company | $420,000 | — |
| lobbied by | Inc. Pfizer | $400,000 | — |
| lobbied by | Inc. Pfizer | $400,000 | — |
| lobbied by | General Motors Company | $390,000 | — |
| lobbied by | General Motors Company | $340,000 | — |
| lobbied by | General Motors Company | $330,000 | — |
| lobbied by | R&d Alternative Simplified Credit Coalition | $330,000 | — |
| lobbied by | Inc. Pfizer | $320,000 | — |
| lobbied by | Inc. Pfizer | $320,000 | — |
| lobbied by | Inc. Pfizer | $320,000 | — |
| lobbied by | Tax Reform Coalition | $320,000 | — |
| lobbied by | Inc. Pfizer | $310,000 | — |
| lobbied by | Inc. Pfizer | $310,000 | — |
| lobbied by | Inc. Pfizer | $300,000 | — |
| lobbied by | Inc. Pfizer | $300,000 | — |
| lobbied by | Caterpillar Inc | $300,000 | — |
| lobbied by | General Motors Company | $300,000 | — |
| lobbied by | Economic Innovation Group | $300,000 | — |
| lobbied by | General Motors Company | $280,000 | — |
| lobbied by | Tax Reform Coalition | $280,000 | — |
| lobbied by | General Motors Company | $280,000 | — |
| lobbied by | General Motors Company | $270,000 | — |
| lobbied by | Inc. Pfizer | $270,000 | — |
| lobbied by | R&d Alternative Simplified Credit Coalition | $260,000 | — |